11.01.2015 Views

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Assessment of Addiction Risk<br />

• Screen<strong>in</strong>g measures for addiction risk:<br />

• STAR/SISAP<br />

• CAGE AIDD<br />

• Opioid Risk Tool (<strong>Emerg<strong>in</strong>g</strong> Solutions <strong>in</strong> Pa<strong>in</strong>)<br />

• SOAPP (see pa<strong>in</strong>edu.org)<br />

• Psychiatric assessment of risk:<br />

• Chemical<br />

• Psychiatric<br />

• Social/Familial<br />

• Genetic<br />

• Spiritual<br />

Position<strong>in</strong>g Opioid Therapy<br />

Opioid Risk Tool<br />

Mark each box that applies. Female Male<br />

1. Family history of substance abuse<br />

– Alcohol<br />

– Illegal drugs<br />

– Prescrib<strong>in</strong>g drugs<br />

2. Personal history of substance abuse<br />

– Alcohol<br />

– Illegal drugs<br />

– Prescrib<strong>in</strong>g drugs<br />

1<br />

2<br />

4<br />

3<br />

4<br />

5<br />

3<br />

3<br />

4<br />

3<br />

4<br />

5<br />

3. Age (mark box if 16-45 years) 1 1<br />

4. History of preadolescent sexual abuse 3 0<br />

5. Psychological disease<br />

– Attention deficit disorder, obsessive compulsive<br />

disorder, bipolar, schizophrenia<br />

– Depression<br />

Scor<strong>in</strong>g: 0-3: low risk; 4-7: moderate risk; ≥8: high risk<br />

2<br />

1<br />

2<br />

1<br />

Webster LR, Webster RM. Pa<strong>in</strong> Med. 2005;6:432-442.<br />

♦No past/current<br />

history of<br />

substance abuse<br />

♦Noncontributory<br />

family history of<br />

substance abuse<br />

♦No major or untreated<br />

psychological<br />

disorder<br />

Stratify Risk<br />

Low Risk Moderate Risk High Risk<br />

♦Significant family<br />

history of<br />

substance abuse<br />

♦Past/co-morbid<br />

psychological<br />

disorder<br />

♦History of treated<br />

substance abuse<br />

♦Active substance<br />

abuse<br />

♦Active addiction<br />

♦Major untreated<br />

psychological<br />

disorder<br />

♦Significant risk<br />

to self and<br />

practitioner<br />

Current Opioid Misuse Measure<br />

(COMM)<br />

• 17-item patient self-assessment : for those<br />

currently on long-term opioid therapy<br />

• S/S <strong>in</strong>toxication, emotional volatility, poor<br />

response to medications, addiction, healthcare<br />

use patterns, problematic medication behavior<br />

• NOT used prior to therapy<br />

Gourlay DL, et al. Pa<strong>in</strong> Med. 2005;6:107-112.<br />

Meltzer et al. Pa<strong>in</strong>. 2011;152:397-402.<br />

Risk Factors for Aberrant<br />

Behaviors/Harm<br />

Restructur<strong>in</strong>g Therapy<br />

to Reduce Risk<br />

Biological<br />

• Age ≤ 45 years<br />

• Gender<br />

• Family history of<br />

prescription drug<br />

or alcohol abuse<br />

• Cigarette smok<strong>in</strong>g<br />

Psychiatric<br />

• Preadolescent sexual<br />

abuse (<strong>in</strong> women)<br />

• Major psychiatric<br />

disorder (eg, personality<br />

disorder, anxiety or<br />

depressive disorder,<br />

bipolar disorder)<br />

• Substance use disorder<br />

Social<br />

• Prior legal problems<br />

• History of motor<br />

vehicle accidents<br />

• Poor family support<br />

• Involvement <strong>in</strong> a<br />

problematic<br />

subculture<br />

• Consider discont<strong>in</strong>uation of opioid<br />

• Cont<strong>in</strong>ue opioid but consider reactive strategies to<br />

improve control over drug use:<br />

• Written agreement (“contract”)<br />

• Frequent visits, small quantities<br />

• Long-act<strong>in</strong>g drugs with no rescue doses<br />

• One pharmacy, pill counts, no replacements<br />

or early scripts<br />

• Ur<strong>in</strong>e drug screens<br />

• Required referrals<br />

Katz NP, et al. Cl<strong>in</strong> J Pa<strong>in</strong>. 2007;23:103-118; Manchikanti L, et al. J Opioid Manage. 2007;3:89-100. Webster LR,<br />

Webster RM. Pa<strong>in</strong> Med. 2005;6:432-442.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!